David Tuller’s three-installment investigation of the PACE trial for chronic fatigue syndrome, “Trial By Error,” has received enormous attention. Although the PACE investigators declined David’s efforts to interview them, they…
…next two involved the licensing deal between King’s College London and Mahana Therapeutics for the Regul8 program. In case you haven’t seen these blogs, here are the links: https://www.virology.ws/2020/01/28/trial-by-error-more-on-the-mahana-therapeutics-deal/ https://www.virology.ws/2020/01/27/trial-by-error-a-commercial-deal-for-kings-college-londons-ibs-cbt-digital-program/…
…T, et al. Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised…
…in discussions about any possible problems with my own work. Readers of Trial By Error know that I am committed to correcting any errors as quickly as possible, whether they…
…2016, after Sir Simon commented on an excellent piece by journalist Julie Rehmeyer on the unraveling of the PACE trial, I tweeted that his remarks were drivel and nonsense. He…
…papers in which participants were recruited before trial registration. 3) The investigators swapped primary and secondary outcomes based on the data provided by these 56 participants recruited before trial registration,…
